Hofseth Biocare ASA: CONTEMPLATING UNSECURED BOND ISSUANCE Hofseth BioCare ASA has retained Novum Asset Management AG to investigate the potential...
Hofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING...
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA...
Hofseth Biocare ASA: FOURTH QUARTER & FULL YEAR 2024 FINANCIAL REPORT HBC achieved full-year sales revenue of NOK 256.8 million, a 35...
Hofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacity Hofseth BioCare ASA ("HBC" or the "Company...
Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT HBC had gross operating revenues of NOK 67.9m (49.9m) in the third quarter and NOK 200.6m...
Hofseth Biocare ASA: CFO RESIGNATION Christel Elise Kanli has decided to step down as Chief Financial Officer (CFO) of Hofseth BioCare ASA (“HBC”...
Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT Ålesund, Norway, 8 October 2024. HBC...
Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT HBC had gross operating revenues of NOK 80.4m (76.4m) in the second...
Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY Ålesund, Norway, 14...
Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc. Ålesund, 02.07.24, Hofseth BioCare ASA...
Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY Hofseth BioCare ASA (HBC) is delighted to announce the...
Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT The first quarter of 2024 continued on the positive trend for HBC. Sales revenues came in...
Hofseth Biocare ASA: Annual General Meeting completed Hofseth BioCare ASA held its Annual General Meeting on 10 May 2024. 270,174,810 shares...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads